Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Reexamination Certificate
2006-10-13
2011-12-13
Badio, Barbara P (Department: 1613)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
C514S211010
Reexamination Certificate
active
08076315
ABSTRACT:
This invention is directed to methods for preventing or ameliorating sleep-related breathing disorders. The method comprises administration to a patient in need thereof an effective dose of one or a combination of prostanoid receptor antagonists (eg. ramatroban, ifetroban, diphloretin, phosphate, polyphloretin phosphate, seratrodast, SC19220). The prostanoid receptor antagonist or combination of prostanoid receptor antagonists can be administered in conjunction with one or more serotonin receptor agonists, one or more cannabinoids receptor agonists, one or more serotonin reuptake inhibitors, one or more noradrenalin reuptake inhibitors, a combination of reuptake inhibitors, an inhibitor of prostanoid synthesis, or any combination of the foregoing.
REFERENCES:
patent: 2004/0105819 (2004-06-01), Hale et al.
patent: 2006/0094082 (2006-05-01), Varadhachary et al.
patent: 0 300 676 (1988-07-01), None
Krieger et al., “Urinary excretiobn of prostanoids during sleep in obstructive sleep apnoea patients”, Clinical and Experimental Pharmacology and Physiology 1991 18:551-555.
Clement et al., “The effects of PGF2alpha on respiratory and cardiovascular variables in PIG”, Prostaglandins and Medicine 1979 3:367-376.
Lee et al., “Pulmonary chemoreflex sensitivity is enhanced by prostaglandin E2 in anesthetized rats”, J. Appl. Physiol. 1995 79(5):1679-1686.
Karlsson et al., “Respiratory and cardiovascular effects of inhaled and intravenous bradykinin, PGE2, and PGF2alpha in dogs”, J. Appl. Physiol. 1993 74(5):2380-2386.
Guerra et al., “Prostaglandin E2 causes hypoventilation and apnea in newborn lambs”, J. Appl. Physiol. 1988 64 (5):2160-2166.
Lim et al., “Aminophylline for the prevention of apnea during prostaglandin E1 infusion”, Pediatrics 2003 112(1):e27-e29.
Taguchi et al., “Prostaglandin E2 inhalation increases the sensation of dyspnea during exercise”, Am Rev Respir Dis 1992 145:1346-1349.
Mohammed et al., “Effects of aerosol-applied capsaicin, histamine and prostaglandin E2 on airway sensory receptors of anaesthetized cats”, Journal of Physiology 1993 469:51-66.
Scott et al., “Chemical mediators of the muscle ergoreflex in chronic heart failure”, Circulation 2006 106:214-220.
Clement et al., “Role of hypotension induced by PGI2 on the control of depth and frequency of breathing”, Prostaglandins and Medicine 1980 5:415-423.
Clement et al., Effects of PGF2alpha on the EMG of costal and crural parts of the diaphragm of the newborn pig, Prostglandins Leukotrienes and Essential Fatty Acids 1991 43:167-173.
Clement et al., “PGF2alpha and breathing pattern in newborn pigs”, Prostglandins Leukotrienes and Essential Fatty Acids 1990 40:103-107.
Preas et al., “Effect of endotoxin on ventilation and breath variability”, Am J Respir Crit Care Med 2001 164:620-626.
Fontana et al., “Prostaglandin synthesis blockade by ketoprofen attenuates respiratory and cardiovascular responses to static handgrip”, J. Appl. Physiol. 1994 78(2):449-457.
Carrithers et al., :Thromboxane A2 mimetic U-46619 induces systemic and pulmonary hypertension and delayed tachypnea in the goat, J. Appl. Physiol. 1994 77(3):1466-1473.
Midorikawa et al., “Effects of prostaglandin E2 inhalation on hypercapnic response in normal subjects”, Am J Respir Crit Care Med 1994 150:1592-1597.
Carley David W.
Radulovacki Miodrag
Badio Barbara P
Licata & Tyrell P.C.
The Board of Trustees of the University of Illinois
Townsley Sara E
LandOfFree
Pharmacological treatments for sleep disorders (apnoe) with... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmacological treatments for sleep disorders (apnoe) with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmacological treatments for sleep disorders (apnoe) with... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4269533